Prochlorperazine Edisylate

   
Google
 
Web NewDrugInformation.com

Prochlorperazine Edisylate


Drug - Prochlorperazine Edisylate
The trade name of the product as shown on the labeling.

Dosage - INJECTABLE; INJECTION
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Prochlorperazine Edisylate
Multiple ingredients are in alphabetical order.

Strength - EQ 5MG BASE/ML
The potency of the active ingredient(s), Prochlorperazine Edisylate. May repeat for multiple part products.

Applicant - STERIS
The firm name holding legal responsibility for Prochlorperazine Edisylate. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 089606
The FDA assigned number to Prochlorperazine Edisylate. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Prochlorperazine Edisylate. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Jul 8, 1987
The date Prochlorperazine Edisylate was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Prochlorperazine Edisylate. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - DISCN
The group or category of approved drugs Prochlorperazine Edisylate is in. Format is RX, OTC, DISCN.

Applicant Full Name - Steris Laboratories Inc
The full name of the firm holding legal responsibility for the new application of Prochlorperazine Edisylate.

Prochlorperazine Edisylate